This innovative approach utilizes functionalized nanomaterials like CNTs and BNNTs combined with UV crosslinking to increase oil melting points. It leverages intermolecular forces and photooxidation to enhance thermal properties, offering potential in industrial applications.
The proposed solution involves enhancing the melting points of oils through the integration of functionalized nanomaterials, specifically carbon nanotubes (CNTs) and boron nitride nanotubes (BNNTs), combined with ultraviolet (UV) crosslinking. This method aims to create chemical linkages within oils that elevate their melting points. By introducing additional intermolecular forces and restricting molecular mobility through nanomaterial inclusion and UV-induced crosslinking, oils achieve a higher energy barrier for melting, thereby improving their thermal stability.
This technology is currently at Technology Readiness Level 3, indicating that it has been demonstrated experimentally in a laboratory setting. Ongoing research focuses on optimizing nanomaterial dispersion, UV exposure conditions, and combinational effects to further validate and enhance the solution's efficacy.
Columbia University is a comprehensive private research university in New York City, combining an Ivy League academic profile with globally engaged scholarship and professional education. Its integration with a major hospital system through Columbia University Irving Medical Center and NewYork-Presbyterian enables clinical collaboration, access to diverse patient populations, and regulated studies at scale. State-of-the-art laboratories and shared core facilities across the Morningside and Manhattanville campuses support co-located industry projects, while proximity to New York’s finance, media, and healthcare ecosystems streamlines talent pipelines and pilot deployments. Industry engages via sponsored research, affiliate programs, executive education, and convenings that connect faculty expertise with corporate R&D priorities. Research is supported by competitive federal funding from agencies such as NIH, NSF, DOE, and DoD, alongside New York State and philanthropic sources. Columbia Technology Ventures provides IP management, licensing, startup support, and translational funding mechanisms that lower barriers to commercialization.